AAAAAA

   
Results: 1-10 |
Results: 10
Is the time from HIV seroconversion a determinant of the risk of AIDS after adjustment for updated CD4 cell counts?
Authors: Babiker, A Darbyshire, N Pezzotti, P Porter, K Rezza, G Walker, S Beral, V Coutinho, R Del Amo, J Gill, N Lee, C Meyer, L Tyrer, F Dabis, F Thiebaut, R Lawson-Ayayi, S Meyer, L Boufassa, F Hamouda, O Lorenzo, JI Touloumi, G Hatzakis, A Karafoulidou, A Katsarou, O Brettle, R del Romero, J Prins, M Coutinho, RA van Benthem, B Coutinho, RA Kirk, O Pedersen, C Aguado, IH Perez-Hoyos, S Eskild, A Bruun, JN Sannes, M Sabin, C Johnson, AM Phillips, AN Darbyshire, JH Francioli, P Vanhems, P Egger, M Rickenbach, M Cooper, D Kaldor, J Vizzard, J Tusell, JM Ruiz, I Cayla, JA de Olalla, PG Day, NE De Angelis, D
Citation: A. Babiker et al., Is the time from HIV seroconversion a determinant of the risk of AIDS after adjustment for updated CD4 cell counts?, J ACQ IMM D, 28(2), 2001, pp. 158-165
Cytomegalovirus seroconversion as a cofactor for progression to AIDS
Authors: Robain, M Boufassa, F Hubert, JB Persoz, A Burgard, M Meyer, L
Citation: M. Robain et al., Cytomegalovirus seroconversion as a cofactor for progression to AIDS, AIDS, 15(2), 2001, pp. 251-256
Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997
Authors: Op de Coul, ELM Prins, M Cornelissen, M van der Schoot, A Boufassa, F Brettle, RP Hernandez-Aguado, I Schiffer, V McMenamin, J Rezza, G Robertson, R Zangerle, R Goudsmit, J Coutinho, RA Lukashov, VV
Citation: Elm. Op De Coul et al., Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997, AIDS, 15(2), 2001, pp. 257-266
Incidence of clinical lipodystrophy in HIV-1-infected patients treated during primary infection
Authors: Goujard, C Boufassa, F Deveau, C Laskri, D Meyer, L
Citation: C. Goujard et al., Incidence of clinical lipodystrophy in HIV-1-infected patients treated during primary infection, AIDS, 15(2), 2001, pp. 282-284
Is cytomegalovirus infection a co-factor in HIV-1 disease progression?
Authors: Robain, M Boufassa, F Hubert, JB Dussaix, E Sadeg, K Meyer, L
Citation: M. Robain et al., Is cytomegalovirus infection a co-factor in HIV-1 disease progression?, EPIDEM INFE, 125(2), 2000, pp. 415-420
Sexual behavior changes and protease inhibitor therapy
Authors: Miller, M Meyer, L Boufassa, F Persoz, A Sarr, A Robain, M Spira, A
Citation: M. Miller et al., Sexual behavior changes and protease inhibitor therapy, AIDS, 14(4), 2000, pp. F33-F39
CCR5 Delta 32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients
Authors: Guerin, S Meyer, L Theodorou, I Boufassa, F Magierowska, M Goujard, C Rouzioux, C Debre, P Delfraissy, JF
Citation: S. Guerin et al., CCR5 Delta 32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients, AIDS, 14(17), 2000, pp. 2788-2790
Effect of ignoring the time of HIV seroconversion in estimating changes insurvival over calendar time in observational studies: results from CASCADE
Authors: Porter, K Babiker, A Walker, S Darbyshire, J Gill, N Beral, V Coutinho, R Darbyshire, J Gill, N Lee, C Meyer, L Rezza, G Porter, K Babiker, A Walker, S Darbyshire, J Tyrer, F Dabis, F Marimoutou, C Meyer, L Boufassa, F Hamouda, O Brunn, M Pezzotti, P Rezza, G Lorenzo, JI Touloumi, G Hatzakis, A Karafoulidou, A Katsarou, O Brettle, R Del Amo, J del Romero, J Prins, M Coutinho, RA van Benthem, B Coutinho, RA Kirk, O Pedersen, C AGuado, IH Perez-Hoyos, S Eskild, A Bruun, JN Sannes, M Sabin, C Lee, C Johnson, AM Phillips, AN Babiker, A Darbyshire, JH Gill, N Porter, K Egger, M Francioli, P Rickenbach, M Cooper, D Kaldor, J Cooper, D Kaldor, J Vizzard, J Tusell, JM Ruiz, I Cayla, JA de Olalla, PG Day, NE De Angelis, D
Citation: K. Porter et al., Effect of ignoring the time of HIV seroconversion in estimating changes insurvival over calendar time in observational studies: results from CASCADE, AIDS, 14(13), 2000, pp. 1899-1906
Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis
Authors: Babiker, A Darby, S De Angelis, D Kwart, D Porter, K Beral, V Darbyshire, J Day, N Gill, N Coutinho, R Prins, M van Benthem, B Coutinho, R Dabis, F Marimoutou, C Ruiz, I Tusell, J Altisent, C Evatt, B Jaffe, H Kirk, O Pedersen, C Rosenberg, P Goedert, J Biggar, R Melbye, M Brettie, R Downs, A Hamouda, O Touloumi, G Karafoulidou, A Katsarou, O Donfield, S Gomperts, E Hilgartner, M Hoots, K Schoenbaum, E Beral, V Zangerle, R Del Amo, J Pezzotti, P Rezza, G Hutchinson, S Day, N De Angelis, D Gore, S Kingsley, L Schrager, L Rosenberg, P Goedert, J Melnick, S Koblin, B Eskild, A Bruun, J Sannes, M Evans, B Lepri, AC Sabin, C Buchbinder, S Vittinghoff, E Moss, A Osmond, D Winkelstein, W Goldberg, D Boufassa, F Meyer, L Egger, M Francioli, P Rickenbach, M Cooper, D Tindall, B Sharkey, T Vizzard, J Kaldor, J Cunningham, P Vanhems, P Vizzard, J Kaldor, J Learmont, J Farewell, V Berglund, O Mosley, J Operskalski, E van den Berg, M Metzger, D Tobin, D Woody, G Rusnak, J Hendrix, C Garner, R Hawkes, C Renzullo, P Garland, F Darby, S Ewart, D Giangrande, P Lee, C Phillips, A Spooner, R Wilde, J Winter, M Babiker, A Darbyshire, J Evans, B Gill, N Johnson, A Phillips, A Porter, K Lorenzo, JI Schechter, M
Citation: A. Babiker et al., Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis, LANCET, 355(9210), 2000, pp. 1131-1137
Do gender differences in CD4 cell counts matter?
Authors: Prins, M Robertson, JR Brettle, RP Aguado, IH Broers, B Boufassa, F Goldberg, DJ Zangerle, R Coutinho, RA van den Hoek, A
Citation: M. Prins et al., Do gender differences in CD4 cell counts matter?, AIDS, 13(17), 1999, pp. 2361-2364
Risultati: 1-10 |